Camille L. Bedrosian - EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP and Chief Medical Officer
Issuer Symbol
RARE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Camille L. Bedrosian since 05 Feb 2025

Holdings reported by Camille L. Bedrosian for Ultragenyx Pharmaceutical Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 46,720 $981,120 $21.00 01 Mar 2023 Direct
Stock Option (Right to Buy) 24,900 01 Mar 2022 Direct Common Stock

Transactions reported by Camille L. Bedrosian for Ultragenyx Pharmaceutical Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.